Iron-induced derangement in hepatic Δ-5 and Δ-6 desaturation capacity and fatty acid profile leading to steatosis: Impact on extrahepatic tissues and prevention by antioxidant-rich extra virgin olive oil.
Animals
Antioxidants
/ administration & dosage
Chromatography, Gas
Delta-5 Fatty Acid Desaturase
Disease Models, Animal
Fatty Acid Desaturases
/ genetics
Fatty Acids
/ analysis
Fatty Liver
/ chemically induced
Gene Expression Regulation, Enzymologic
/ drug effects
Iron
/ adverse effects
Linoleoyl-CoA Desaturase
/ genetics
Male
Olive Oil
/ administration & dosage
Rats
Rats, Wistar
Antioxidant-rich extra virgin olive oil
Iron
LCPUFAs
Liver steatosis
Δ5- and Δ6-desaturases
Journal
Prostaglandins, leukotrienes, and essential fatty acids
ISSN: 1532-2823
Titre abrégé: Prostaglandins Leukot Essent Fatty Acids
Pays: Scotland
ID NLM: 8802730
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
23
09
2019
revised:
27
11
2019
accepted:
21
01
2020
pubmed:
3
2
2020
medline:
22
9
2020
entrez:
3
2
2020
Statut:
ppublish
Résumé
The administration of iron induces liver oxidative stress and depletion of long-chain polyunsaturated fatty acids (LCPUFAs), n-6/n-3 LCPUFA ratio enhancement and fat accumulation, which may be prevented by antioxidant-rich extra virgin olive oil (AR-EVOO) supplementation. Male Wistar rats were subjected to a control diet (50 mg iron/kg diet) or iron-rich diet (IRD; 200 mg/kg diet) with alternate AR-EVOO for 21 days. Liver fatty acid (FA) analysis was performed by gas-liquid chromatography (GLC) after lipid extraction and fractionation, besides Δ-5 desaturase (Δ-5 D) and Δ6-D mRNA expression (qPCR) and activity (GLC) measurements. The IRD significantly (p < 0.05) increased hepatic total fat, triacylglycerols, free FA contents and serum transaminases levels, with diminution in those of n-6 and n-3 LCPUFAs, higher n-6/n-3 ratios, lower unsaturation index and Δ5-D and Δ6-D activities, whereas the mRNA expression of both desaturases was enhanced over control values, changes that were prevented by concomitant AR-EVOO supplementation. N-6 and n-3 LCPUFAs were also decreased by IRD in extrahepatic tissues and normalized by AR-EVOO. In conclusion, AR-EVOO supplementation prevents IRD-induced changes in parameters related to liver FA metabolism and steatosis, an effect that may have a significant impact in the treatment of iron-related pathologies or metabolic disorders such as non-alcoholic fatty liver disease.
Identifiants
pubmed: 32007744
pii: S0952-3278(19)30194-2
doi: 10.1016/j.plefa.2020.102058
pii:
doi:
Substances chimiques
Antioxidants
0
Delta-5 Fatty Acid Desaturase
0
Fatty Acids
0
Olive Oil
0
Iron
E1UOL152H7
Fatty Acid Desaturases
EC 1.14.19.-
Linoleoyl-CoA Desaturase
EC 1.14.19.3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102058Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.